ESC Professional Premium Access

Diagnostic methods in cardiac amyloidosis and other rare cardiomyopathies

Event: ESC Congress 2022
Topic: Diagnostic Methods
Session type: Moderated ePosters
Date: 26 August 2022
Time: 14:15 - 15:00

Congress Session

7 presentations in this session

The predictive value of left atrial diameter for thrombotic risk in patients with left ventricular noncompaction

Speaker: Doctor W. Xu (Beijing, CN)
Thumbnail

Cardiac injury before and after COVID-19. A longitudinal MRI study

Speaker: Doctor T. Althoff (Barcelona, ES)
Thumbnail

Early subclinical systolic dysfunction detected by two-dimensional speckle tracking systolic strain in patients with hereditary TTR amyloidosis

Speaker: Miss L. Squassante Capeline (Sao Paulo, BR)
Thumbnail

Validation of an electrocardiographic algorithm for the detection of cardiac amyloidosis

Speaker: Doctor L. Schrutka (Vienna, AT)
Thumbnail

Prognostic value of left ventricle global constructive work in patients with cardiac amyloidosis

Speaker: Doctor J. Geers (Brussels, BE)
Thumbnail

Echocardiographic evolution of patients undergoing 99mTc-DPD scintigraphy for suspected cardiac amyloidosis

Speaker: Mrs N. Ramos Lopez (Madrid, ES)
Thumbnail

Does my TAVR patient have cardiac amyloidosis?

Speaker: Doctor J. Borges-Rosa (Coimbra, PT)
Thumbnail

7 speakers from this session

Doctor Wei Xu

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)
0 follower

Doctor Till F Althoff

Hospital Clinic, University of Barcelona, Barcelona (Spain)
0 follower

Miss Lorena Squassante Capeline

Federal University of Sao Paulo (UNIFESP), Sao Paulo (Brazil)
1 follower

Doctor Lore Schrutka

Medical University of Vienna, Vienna (Austria)
0 follower

Doctor Jolien Geers

University Hospital (UZ) Brussels, Brussels (Belgium)
0 follower

Mrs Noemi Ramos Lopez

San Carlos Clinical University Hospital, Madrid (Spain)
0 follower

Doctor Joao Borges-Rosa

Coimbra Hospital and University Center, Coimbra (Portugal)
0 follower

This platform is supported by

logo Novo Nordisk